As stated by Bayer AG Stockholders’ Newsletter First Quarter 2013:
- The number of Yaz / Yasmin lawsuits pending in the United States and served upon Bayer was around 10,200
- 1,340 claims are pending that have not been filed in court
- Excluding claims already settled; there are 14,500 claimants in pending lawsuits that allege they have suffered personal injuries and even death from the use of Yasmin, Yaz, Ocella and/or Gianvi (the generic version of Yaz)
- Bayer agreed to settle the claims without admitting liability, of about 5,700 claimants in the U.S. totaling almost $1.18 billion U.S. dollars
- Bayer is only settling claims in the United States for DVT or Deep Vein Thrombosis
Contact Our Yasmin Lawsuit Attorneys
An experienced Yaz and Yasmin lawsuit attorney can help you file a lawsuit to recover the compensation to which you are entitled. Our Yasmin lawyers have extensive experience with dangerous drug cases and have specifically handled many Yaz and Yasmin birth control claims.
Our legal team will aggressively represent you to obtain full compensation for your injury. Contact our Yaz and Yasmin lawsuit attorneys today. We will protect your rights.
Yaz is a birth control pill or oral contraceptive that contains the synthetic female hormone, progesterone called “drospirenone”.
Drospirenone, is a dangerous drug that causes many adverse effects including, DVT (deep vein thrombosis) and blood clots which in turn can cause heart attack, stroke, pulmonary embolisms and even death.
Birth control pills containing drospirenone include:
Yaz, Yasmin, BeYaz, Ocella, Yasminelle, Zarah and Angeliq
Bayer AG, the manufacturer of yaz and yasmin announced settlements totaling over $400,000 U.S. dollars as of August 2012. There have been at least 1,900 cases resolved claiming the birth control pills caused heart attacks and/or strokes. Bayer AG, paid out an average of $212,000 U.S. dollars per case.
Birth control pills containing drospirenone are required to include the following information:
A summary of previously released results of the FDA funded study regarding the blood clot risk, and that some epidemiologic studies show as high as a threefold increased risk for blood clots for birth control pills containing drospirenone.
If you believe that you or a loved one has suffered injury or death due to a defective or dangerous pharmaceutical, you may have the right to compensation for your injuries. The Maher Law Firm and Frank M. Eidson would like to help. We invite you to contact our trial tested Yaz, Yasmin & Ocella Lawyers today.
Bayer AG pays out an average of $212,000 per Yaz and Yasmin case
In a stockholders’ newsletter in July, Bayer said that it’s resolved almost 1,900 cases in which it’s alleged that its Yasmin and Yaz contraceptives caused clots that can lead to heart attacks and strokes.
Bayer AG, based in Leverkusen, Germany put aside a total of $246 million U.S. dollars in 2010 and 2011, according to securities filings, and has now more than doubled it’s reserve for Yaz and Yasmin cases to $610.5 million U.S. dollars.
Bloomberg Report - In an emailed statement, Bayer officials said “We believe we have made appropriate provisions for most of the cases we consider to be worthy of settlement with these accounting measures.”
It is said that Bayer may have to pay more than 2.5 Billion U.S. dollars to resolve all the cases over Yaz and Yasmin.
If you believe that you or a loved one has suffered injury or death due to a defective or dangerous pharmaceutical, you may have a right to compensation for your injuries. The Yaz and Yasmin Lawyers at The Maher Law Firm would like to help. We invite you to contact our trial-tested dangerous drug attorneys today.
The first Yaz trial, which involves a plaintiff who suffered a pulmonary embolism after taking the drospirenone-containing birth control pill, was set to begin on January 9th. However, the federal judge overseeing thousands of Yaz, Yasmin and Ocella venous thromboembolism lawsuits, instead ordered that all involved parties meet with a special mediator in order to negotiate a settlement for the litigation.
Judge Herndon’s December 31st order has delayed the start of a trial that was likely going to help both the prosecution and the defense gauge how juries would react and respond to the evidence presented in many of the cases. Stephen Saltzburg, a professor at the George Washington School of Law, was the Special Master appointed to mediated the entire litigation.
To date, more than 10,500 women have filed product liability lawsuits against Bayer AG, alleging that they suffered injuries as a result of Bayer’s failure to properly warn users of the potentially dangerous side effects of Yasmin, Yaz and other drospirenone-containing birth control pills.
According to a recent report by the U.S. Food and Drug Administration, birth control pills that contain drospirenone, a new kind of synthetic progestin, may increase the risk for blood clots by as much as 75 percent over older-generation birth control pills.
On October 25, 2011, The British Medical Journal published a study confirming previous findings that newer-generation birth control pills, specifically those containing the progestogen hormones drospirenone, desogestrel or gestodene, double the risk for venous thromboembolism (VTE), compared to older-generation contraceptives containing the progestogen hormone, levonorgestrel. Widely-used and incredibly popular brands like as Yasmin, Yaz and Ocella are all examples of the types of birth control pills currently under intense scrutiny by the U.S. Food and Drug Administration, as well as other regulatory agencies and watchdog groups.
The study, which was led by Dr. Ojvind Lidegaard of the University of Copenhagen, included approximately 1.2 million non-pregnant women between the ages of 15 and 49 with no previous history of thrombotic disease. The results revealed that women taking older-generation birth control pills were three times more likely to develop VTE, compared to those not taking any hormonal contraceptive. Alarmingly, however, women taking drospirenone-containing birth control pills were at six to seven times the risk for VTE compared to non-users. The data undoubtedly confirms that women taking newer-generation birth control pills are at an increased risk for developing potentially serious and even life-threatening blood clots.
VTE is a blood clot that forms deep within a leg vein, and can be especially dangerous (even deadly) if the clot travels to the heart, brain or lungs. Women taking a drospirenone-containing birth control pills, should be aware of the warning signs of VTE, which include continuous and severe leg pain, severe chest pain or shortness of breath.
After a thorough search of the FDA’s adverse events database, a German research group found there have been 190 Yaz or Yasmin related deaths in the United States alone.
Most of the women were young and healthy when they started taking the oral contraceptive. They then suddenly developed blood clots, pulmonary embolisms, suffered a stroke or gallbladder disease.
Currently, there are about 7000 lawsuits against Bayer, the makers of Yaz and Yasmin. The German research group called Coalition against Bayer Dangers, or CBG would like to have women who suffered a Yaz side effect speak out at a Bayer shareholder meeting; Because of the high number of injuries, CBG aims to ask the drug makers to recall their best-selling birth control pill.
Birth Control Buzz is a website dedicated helping women find the best and best priced birth control pills for themselves. They also have a forum where people can post their experiences both good and bad with various pills. There, one mother wrote: “My daughter was taking Yaz as a predecessor to going on Acutane for acne. After a couple months began having severe nausea and vomiting which we thought was due to the Acutane (it is known to have potentially powerful side effects) so we took her off of that treatment. The nausea and vomiting increased to the extent that she had MRI, sonogram, and ultimately colonoscopy and endoscopy to determine if there was cancer, etc. All tests were totally clean…so doctors said it must be in her head.”
As it turned out it wasn’t just “in her head”; The mother was able to trace the start of her daughter’s problems back and found it coincided with the start of the Yaz prescription. She writes: “I immediately told her to stop taking the drug. Within one week, my daughter could eat again and her spirits were lifted. Nice to have her back after thousands of dollars in medical tests.”
Yaz has caused adverse side effects for many women, including life-threatening cases of pulmonary embolism, deep vein thrombosis, and even stroke. Lawsuits have been and continue to be filed against Bayer, makers of Yaz.